Volume 69, Issue 6, Pages (December 2018)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Volume 67, Issue 3, Pages (September 2017)
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
MELD: the holy grail of organ allocation?
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
m-TOR inhibitors: What role in liver transplantation?
m-TOR inhibitors: What role in liver transplantation?
Volume 66, Issue 3, Pages (March 2017)
Volume 61, Issue 6, Pages (December 2014)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Volume 51, Issue 6, Pages (December 2009)
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
Living donor liver transplantation: is the hype over?
Clinical Approach to the Patient With Abnormal Liver Test Results
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Liver Failure Secondary to Amyloid Light-Chain Amyloidosis
Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure”  Rakhi Maiwall,
Juice Plus or Toxicity Plus
Pretransplantation Liver Function Impacts on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Study of 455 Patients  Pere Barba, José.
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 62, Issue 3, Pages (March 2015)
Acute hepatitis C: Current status and remaining challenges
Ming-Ling Chang, Yun-Fan Liaw  Journal of Hepatology 
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
Prevalence of Elevated Alanine Aminotransferase Among US Adolescents and Associated Factors: NHANES 1999–2004  Abigail Fraser, Matthew P. Longnecker,
Laboratory parameter profiles among patients with cystic fibrosis
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Volume 69, Issue 5, Pages (November 2018)
Volume 70, Issue 3, Pages (March 2019)
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 50, Issue 3, Pages (March 2009)
Volume 67, Issue 3, Pages (September 2017)
Immigration and viral hepatitis
Joint Effects of Body Weight and Alcohol on Elevated Serum Alanine Aminotransferase in the United States Population  Constance E. Ruhl, James E. Everhart 
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection  Isabelle Chemin,
The use of hemospray in portal hypertensive bleeding; a case series
Volume 66, Issue 3, Pages (March 2017)
Volume 66, Issue 4, Pages (April 2017)
m-TOR inhibitors: What role in liver transplantation?
Reviewer Acknowledgment
Volume 46, Issue 3, Pages (March 2007)
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
The relationship between age and fat infiltration in liver and muscle
MELD: the holy grail of organ allocation?
LINDA S. SNYDER, M.D., RUSSELL I. HEIGH, M.D., MONTE L. ANDERSON, M.D. 
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child
Presentation transcript:

Volume 69, Issue 6, Pages 1396-1397 (December 2018) Incidence of grade 3-4 liver injury under immune checkpoints inhibitors: A retrospective study  Lucia Parlati, Anais Vallet-Pichard, Rui Batista, Alain Hernvann, Philippe Sogni, Stanislas Pol, Vincent Mallet  Journal of Hepatology  Volume 69, Issue 6, Pages 1396-1397 (December 2018) DOI: 10.1016/j.jhep.2018.08.014 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Frequencies of grade 3 and 4 AST/ALT/GGT/ALP and total bilirubin elevations among immune checkpoint inhibitor (n = 303) and control (n = 299,491) patients over an eight-year observational period in a teaching hospital. Differences between groups were computed with logistic regressions adjusted for age, sex, and prescription unit. **p <0.05, ***p <0.001. ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma glutamyl transferase. Journal of Hepatology 2018 69, 1396-1397DOI: (10.1016/j.jhep.2018.08.014) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions